Friday 12 August 2011

CRA or CRA II - Hungary - 8347

An exciting opportunity has arisen in this leading CRO for a CRA role with clinical responsibility for Hungary!

You will be responsible for leading a team of experienced CRAs across a range of high profile oncology projects! When you work for this medium sized, well respected company you work for a company specialising in supporting the development of new drugs in a wide range of therapeutic areas: oncology in particular, as well as CNS and cardiovascular sciences.

With an international presence and high profile pharmaceutical and biotechnology clients, the company offers an excellent environment in which to develop your career further. In this role you will be responsible for clinical study sites based in Hungary from initial start up through to close out across phase II and III projects with an international scope. Within these projects you will be responsible for all site management and core monitoring activities, site specific training, clinical site budgets and management of site level relationships. This company offers excellent training and development to its CRAs, both internally and externally, along with ongoing performance monitoring to help you develop your career, either into clinical management or project management, with the company.

Who are we looking for? You will be an experienced CRA able to demonstrate the ability to manage all aspects of site activity from set up through to close-out in Hungary. Experience in the monitoring of oncology studies is essential. On offer is a competitive renumeration package, excellent training and development, and the opportunity to become part of a talented international team!

For more information or to register your interest please contact Kristina on kristina@seltekconsultants.co.uk
Please note that by applying to this role, you are only expressing your interest; I will discuss the role and company in detail with you before your CV is submitted to our client.


Click here to apply

No comments:

Post a Comment